Famotidine

Manufacturer
Wal-Mart Stores Inc
Effective date
2024-10-22
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
legacy-cache
Hydrated at
2026-08-01 20:51:23

Label at a glance#

ProductFamotidine
Active ingredientFAMOTIDINE
Label structure13 sections

Indications and uses

relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

Dosage and administration

For Famotidine 10 mg: adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew. to prevent symptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes before eating food or drinking beverages that cause heartburn do not use more than 2 tablets in 24 hours children under 12 years: ask a doctor For Famotidine 20 mg: adults and children 12 ...

Storage and handling

read the directions and warnings before use keep the carton. It contains important information. store at 20°-25°C (68°-77°F) [See USP controlled Room Temperature] protect from moisture and light

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Famotidine USP, 10 mg/20 mg

Purpose

OTC - PURPOSE SECTION

Acid reducer

Uses

INDICATIONS & USAGE SECTION

  • relieves heartburn associated with acid indigestion and sour stomach
  • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • if you have kidney disease, except under the advice and supervision of a doctor (for Famotidine 20 mg)
  • with other acid reducers

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating, or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • For Famotidine 10 mg:
  • adults and children 12 years and over:
  • to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
  • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 15 to 60 minutes before eating food or drinking beverages that cause heartburn
  • do not use more than 2 tablets in 24 hours
  • children under 12 years: ask a doctor
  • For Famotidine 20 mg:
  • adults and children 12 years and over:
  • to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
  • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
  • do not use more than 2 tablets in 24 hours
  • children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • read the directions and warnings before use
  • keep the carton. It contains important information.
  • store at 20°-25°C (68°-77°F) [See USP controlled Room Temperature]
  • protect from moisture and light

Inactive ingredients

INACTIVE INGREDIENT SECTION

colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, synthetic red iron oxide (only in 10 mg), talc and titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

Call 1-888-375-3784

Tips for Managing Heartburn

SPL UNCLASSIFIED SECTION

Tips for Managing Heartburn

  • Do not lie flat or bend over after eating
  • Do not wear tight-fitting clothing around the stomach
  • Do not eat before bedtime
  • Raise the head of your bed
  • Avoid heartburn-causing foods such as rich, spicy, fatty or fried foods, chocolate, caffeine, alcohol and certain fruits and vegetables
  • Eat slowly and avoid big meals
  • If overweight, lose weight
  • Quit smoking

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Famotidine 10 mg

Container Carton Label 30 count container10mgcontainer10mg

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Famotidine 10 mg

Container Carton Label 90 countcontainer10mgcontainer10mg

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Famotidine 10 mg

Blsiter Carton 12 count

blistercartonblistercarton

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
49035-118FAMOTIDINE TABLET [WAL-MART STORES INC]7Legacy NDC20241025_c8171b38-0dfd-d2b0-9331-8a82c29c8ab2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49035-118-90EA - Each49035-118b4a08494-45e9-4607-9596-3731e3267cf812019-04-11
55111-118-90EA - Each55111-118b0358378-0ed2-4912-b058-89e7e6d918f712021-04-08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
FAMOTIDINEACTIVE INGREDIENT5QZO15J2Z82
FAMOTIDINEACTIVE MOIETY5QZO15J2Z82
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61U2
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6752
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WO2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I302
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU42
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJ2
TALCINACTIVE INGREDIENT7SEV7J4R1U2
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JP2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49035-11849035-118-30, 49035-118-90, 49035-118-12
55111-118

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / ORAL8 mgExact identifier — unii+route+dosage form
CELLULOSE, MICROCRYSTALLINEMICROCRYSTALLINE CELLULOSEOP1R32D61UTABLET / ORAL6184 mgExact identifier — unii+route+dosage form
STARCH, CORNSTARCH, CORNO8232NY3SJTABLET / ORAL1116 mgExact identifier — unii+route+dosage form
TALCTALC7SEV7J4R1UTABLET / ORAL1000 mgExact identifier — unii+route+dosage form
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / ORAL750 mgExact identifier — unii+route+dosage form
HYPROMELLOSESHYPROMELLOSE3NXW29V3WOTABLET / ORAL1127 mgExact identifier — unii+route+dosage form
TITANIUM DIOXIDETITANIUM DIOXIDE15FIX9V2JPTABLET / ORAL232 mgExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077367-001FAMOTIDINEFAMOTIDINE20MGTABLET / ORAL2006-09-25
A077367-002FAMOTIDINEFAMOTIDINE10MGTABLET / ORAL2001-08-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-2584e616aacf4f…
2026-09-14 22:38:342026-08A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-1784e616aacf4f…
2026-08-18 06:07:402026-07A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25caaa826d4ba7…
2026-08-18 06:07:402026-07A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25011fe1cb6892…
2026-02-19 14:30 UTC2026-02A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-2531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-256a471c1ec25d…
2025-08-23 18:47 UTC2025-08A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-2503ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-252680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-255bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25d06236e962d9…
2024-10-29 15:01 UTC2024-10A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-2579d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-251e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-258072bd15b7f6…
2024-05-31 18:47 UTC2024-05A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-255c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-255d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-254b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A077367-002FAMOTIDINE10MGTABLET / ORAL2001-08-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-2574a2ff9319b5…
2022-03-09 01:35 UTC2022-03A077367-001FAMOTIDINE20MGTABLET / ORAL2006-09-25bb7c543d1eb4…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9edcf860-f9b1-943a-eb5c-7ec93dd92398c8171b38-0dfd-d2b0-9331-8a82c29c8ab22025-07-17WarningsExact identifier
spl set id: c8171b38-0dfd-d2b0-9331-8a82c29c8ab2
FamotidineFAMOTIDINEDr.Reddys Laboratories Limited387088a6-8eaa-fc49-8050-a546d0f0fd322025-06-03WarningsExact identifier
ndc (product): 55111-118

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.